Incidence, Predictors and Validation of Risk Scores to Predict Myocardial Infarction After Noncardiac Vascular Surgery

Sponsor
Centro Hospitalar De São João, E.P.E. (Other)
Overall Status
Completed
CT.gov ID
NCT04051749
Collaborator
(none)
306
6.9

Study Details

Study Description

Brief Summary

Evaluate the incidence and predictors of post-operative mortality after noncardiac Vascular Surgery and compare the performance of existing risk scores.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Noncardiac Vascular Surgery

Study Design

Study Type:
Observational
Actual Enrollment :
306 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Incidence, Predictors and Validation of Risk Scores to Predict Myocardial Infarction After Noncardiac Vascular Surgery, a Cohort Prospective Study
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Apr 30, 2015
Actual Study Completion Date :
Jul 31, 2015

Arms and Interventions

Arm Intervention/Treatment
Patients submitted to VS

Procedure: Noncardiac Vascular Surgery
Noncardiac Vascular Surgery

Outcome Measures

Primary Outcome Measures

  1. Major Cardiac Events [30-day]

Secondary Outcome Measures

  1. Mortality [30-day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Elective arterial Vascular Surgery

  • Patients > 18 years

Exclusion Criteria:
  • Urgent/Emergent Surgery

  • Patients < 18 years

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centro Hospitalar De São João, E.P.E.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pedro Reis, Principal Investigator, Centro Hospitalar De São João, E.P.E.
ClinicalTrials.gov Identifier:
NCT04051749
Other Study ID Numbers:
  • CES 04-15
First Posted:
Aug 9, 2019
Last Update Posted:
May 14, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2020